235 related articles for article (PubMed ID: 34357048)
1. Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.
Găman MA; Cozma MA; Dobrică EC; Crețoiu SM; Găman AM; Diaconu CC
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357048
[TBL] [Abstract][Full Text] [Related]
2. Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.
Găman MA; Kipkorir V; Srichawla BS; Dhali A; Găman AM; Diaconu CC
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830925
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Sankar K; Stein BL; Rampal RK
Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
[TBL] [Abstract][Full Text] [Related]
4. Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Duangnapasatit B; Rattarittamrong E; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
Asian Pac J Cancer Prev; 2015; 16(12):5013-8. PubMed ID: 26163633
[TBL] [Abstract][Full Text] [Related]
5. Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature.
Găman MA; Cozma MA; Manan MR; Srichawla BS; Dhali A; Ali S; Nahian A; Elton AC; Simhachalam Kutikuppala LV; Suteja RC; Diebel S; Găman AM; Diaconu CC
World J Clin Oncol; 2023 Mar; 14(3):99-116. PubMed ID: 37009527
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative Neoplasms in Children.
Hofmann I
J Hematop; 2015 Sep; 8(3):143-157. PubMed ID: 26609329
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review.
Al-Mashdali AF; Aldapt MB; Rahhal A; Hailan YM; Elhakeem I; Ali EA; Rozi W; Yassin MA
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766480
[TBL] [Abstract][Full Text] [Related]
8. Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms.
Elsayed B; Elshoeibi AM; Elhadary M; Ferih K; Elsabagh AA; Rahhal A; Abu-Tineh M; Afana MS; Abdulgayoom M; Yassin M
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980431
[TBL] [Abstract][Full Text] [Related]
9. Risk of hepatitis B reactivation in patients with myeloproliferative neoplasms treated with ruxolitinib.
Adesola AA; Cozma MA; Chen YF; Srichawla BS; Găman MA
World J Hepatol; 2023 Nov; 15(11):1188-1195. PubMed ID: 38075009
[TBL] [Abstract][Full Text] [Related]
10. Methylation of SOCS3 in Myeloproliferative Neoplasms and Secondary Erythrocytosis/Thrombocythemia.
Torun D; Nevruz O; Akyol M; Kozan S; Bahçe M; Güran S; Beyan C
Turk J Haematol; 2013 Mar; 30(1):13-8. PubMed ID: 24385747
[TBL] [Abstract][Full Text] [Related]
11. The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases.
Pizzi M; Croci GA; Ruggeri M; Tabano S; Dei Tos AP; Sabattini E; Gianelli U
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830822
[TBL] [Abstract][Full Text] [Related]
12. Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Ferreira Cristina S; Polo B; Lacerda JF
Semin Hematol; 2018 Oct; 55(4):215-222. PubMed ID: 30502850
[TBL] [Abstract][Full Text] [Related]
13. [Myeloproliferative neoplasms - Update on diagnosis and treatment].
Meyer SC; Drexler B; Skoda RC
Ther Umsch; 2019; 76(9):487-495. PubMed ID: 32157965
[TBL] [Abstract][Full Text] [Related]
14. Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms.
Krečak I; Peran N; Lapić I; Gverić-Krečak V; Krečak F; Rončević P; Duraković N
Wien Klin Wochenschr; 2021 Jan; 133(1-2):62-64. PubMed ID: 32300883
[TBL] [Abstract][Full Text] [Related]
15. Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.
Agarwal MB; Malhotra H; Chakrabarti P; Varma N; Mathews V; Bhattacharyya J; Seth T; Gayathri K; Menon H; Subramanian PG; Sharma A; Bhattacharyya M; Mehta J; Vaid AK; Shah S; Aggarwal S; Gogoi PK; Nair R; Agarwal U; Varma S; Prasad SV; Manipadam MT
Indian J Med Paediatr Oncol; 2015; 36(1):3-16. PubMed ID: 25810569
[TBL] [Abstract][Full Text] [Related]
16. Environmental Factors, Lifestyle Risk Factors, and Host Characteristics Associated With Philadelphia Negative Myeloproliferative Neoplasm: A Systematic Review.
Allahverdi N; Yassin M; Ibrahim M
Cancer Control; 2021; 28():10732748211046802. PubMed ID: 34645293
[TBL] [Abstract][Full Text] [Related]
17. Myeloproliferative neoplasia: a review of clinical criteria and treatment.
Koopmans SM; van Marion AM; Schouten HC
Neth J Med; 2012 May; 70(4):159-67. PubMed ID: 22641623
[TBL] [Abstract][Full Text] [Related]
18. CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.
Kim SY; Im K; Park SN; Kwon J; Kim JA; Lee DS
Am J Clin Pathol; 2015 May; 143(5):635-44. PubMed ID: 25873496
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
Michiels JJ; Kutti J; Stark P; Bazzan M; Gugliotta L; Marchioli R; Griesshammer M; van Genderen PJ; Brière J; Kiladjian JJ; Barbui T; Finazzi G; Berlin NI; Pearson TC; Green AC; Fruchtmann SM; Silver RT; Hansmann E; Wehmeier A; Lengfelder E; Landolfi R; Kvasnicka HM; Hasselbalch H; Cervantes F; Thiele J
Neth J Med; 1999 Feb; 54(2):46-62. PubMed ID: 10079679
[TBL] [Abstract][Full Text] [Related]
20. Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
Yung Y; Lee E; Chu HT; Yip PK; Gill H
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
